NYSE:PFE
Pfizer Inc (PFE)
30.03
-0.39 (1.28%)
as of Oct 23, 2026, 8:00:00 pm Market Closed.
585 watching
Financials 
Technical Analysis 0
BUY
A real defensive story. Have tremendous internal cash flow. Have a sound dividend and they buy back stocks. A real value play. New drugs coming out are really solid.
Paul Gardner, CFAOwned
biotechnologypharmaceutical
BUY
Got rid of a lot of their past problems. The whole drug sector has been a difficult place to be because of pricing pressures, lawsuits, etc. The worst is now over. Large pharmaceuticals are international, so as the US$ drops, their foreign assets increase.
Norman LevineOwned
biotechnologypharmaceutical
BUY
A cheap company. The sector is cheap. Really great yield. Expects they will be getting rid of their consumer products division this year, which will give the stock a boost.
Paul Harris, CFAOwned
biotechnologypharmaceutical
BUY
Near 4% yield which is very attractive. Good level to buy. Trading at about 12 X earnings. Gives about 35% return on equity. No debt.
Laura WallaceOwned
biotechnologypharmaceutical
TOP PICK
His model price is $38, a 49% positive differential. Pays a nice fat dividend.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
Has an ace dividend yield of about 3%. Turning things around. Have a good pipeline. Has there consumer products operation up for sale but thinks they will spin it out to the shareholders. Very little downside risk.
Norman LevineOwned
biotechnologypharmaceutical
BUY
Owns Teva (TEVA-Q) as a growth stock and owns this one as a value stock. This one seems to be doing things correctly, more so than Merk (MRK-N). Feels the environment has bottomed out and will be getting better. Low risk.
Norman LevineOwned
biotechnologypharmaceutical
BUY
Likes the pharmaceutical sector. This one is very cheap. Dividend of 3.5%. Trading at 10 X earnings.
Paul Harris, CFAOwned
biotechnologypharmaceutical
BUY
The fundamental outlook is improving. The worst is behind it. The company is swimming in cash. There could be another dividend increase.
Norman LevineOwned
biotechnologypharmaceutical
BUY
Pfizer is a large cap pharma. Probably the largest pharma company in the world. Has suffered along with the rest of the industry. It is well positioned. Very attractive. Good dividend yield. Predicts it will continue to grow 12-15%.
Laura WallaceOwned
biotechnologypharmaceutical
BUY
He likes this industry. The growth is not what it used to be. Evaluations are cheaper than they have been in a long time. Growth stocks are cheaper than they have been in last 20 years.
John ZechnerOwned
biotechnologypharmaceutical
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
